Stocks
›
Press Release
Advertise
USD
EN
App
Download App
Crypto
Stocks
Forex
Metals
Portfolio
Exchanges
Token Sales
News
Tools
Hotspot
Close
Home
Stocks
MANE
News
Market Closed
MANE
Veradermics, Incorporated
$ 129.66
-4.16%
Last 24H
Trading with leverage comes with a high risk and may not be suitable for everyone.
Trading with leverage comes with a high risk and may not be suitable for everyone.
Watchlist
Portfolio
Updated a day ago
Overview
Price Prediction
Brokers
News
Dividend
Earnings
Veradermics, Incorporated News
Latest Veradermics, Incorporated Stock News & MANE Headlines
Veradermics Reports Third Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
5 days
ago |
businesswire.com
Veradermics, Incorporated (MANE) Discusses Positive Study 302 Part B Results for VDPHL01 in Pattern Hair Loss Transcript
5 days
ago |
seekingalpha.com
Veradermics Achieved the Highest VDPHL01 Reported Hair Count in the Phase 3 Program to Date in Positive 12-Month Study '302' Data in Male Pattern Hair Loss
6 days
ago |
businesswire.com
Veradermics to Hold Conference Call to Discuss 12-Month Long-Term Results from Phase 3 '302' Clinical Trial of VDPHL01 in Males with Mild-to-Moderate Pattern Hair Loss
6 days
ago |
gurufocus.com
Veradermics to Hold Conference Call to Discuss 12-Month Long-Term Results from Phase 3 ‘302' Clinical Trial of VDPHL01 in Males with Mild-to-Moderate Pattern Hair Loss
6 days
ago |
businesswire.com
Veradermics, Incorporated (MANE) Discusses Positive Top Line Results From Phase III Study 304 of VDPHL01 in Male Pattern Hair Loss Transcript
a month
ago |
seekingalpha.com
Veradermics Phase III Hair Loss Trial Meets All Endpoints, Posts Strong Growth Results
a month
ago |
marketbeat.com
Veradermics' Oral VDPHL01 Achieved Early, Consistent, and Robust Hair Growth in Positive Phase 3 ‘304' Clinical Trial in Male Pattern Hair Loss
a month
ago |
businesswire.com
Veradermics to Hold Conference Call to Discuss Topline Results from Phase 3 ‘304' Clinical Trial of VDPHL01 in Males with Mild-to-Moderate Pattern Hair Loss
a month
ago |
businesswire.com
Veradermics, Incorporated (NYSE:MANE) Receives Consensus Rating of “Moderate Buy” from Brokerages
2 months
ago |
defenseworld.net
Load More
Download App
Keep track of your holdings and explore over 40,000 cryptocurrencies
Market Closed
MANE
Veradermics, Incorporated
$ 129.66
-4.16%
Last 24H
Trading with leverage comes with a high risk and may not be suitable for everyone.
Trading with leverage comes with a high risk and may not be suitable for everyone.
Watchlist
Portfolio
Updated a day ago
People Also Watch
Top
Gainers
Losers
Symbol
Last Price
24H CNG
AAPL
$ 356.27
0.39%
NVDA
$ 162.85
-2.01%
MSFT
$ 523.88
0.17%
GOOG
$ 292.52
-0.96%
AMZN
$ 266.66
-0.29%
Explore our Tools
Watchlist
Portfolio
Alerts
Market Overview
Converter
ICO Calendar
Stocks
Never miss a story...
Subscribe to Newsletter